» Articles » PMID: 21251063

Focal Nodular Hyperplasia or Focal Nodular Hyperplasia-like Lesions of the Liver: a Special Emphasis on Diagnosis

Overview
Specialty Gastroenterology
Date 2011 Jan 22
PMID 21251063
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aim: Focal nodular hyperplasia (FNH) and FNH-like lesions are hypervascular masses that can mimic hepatocellular carcinoma (HCC). We have investigated the clinical, radiological and pathological features of FNH and FNH-like lesions of the liver, with particular focus on the aspect of diagnosis.

Methods: A total of 84 patients, 77 with pathologically-proven FNH and seven with FNH-like lesions of the liver, were analyzed retrospectively.

Results: Of the 84 patients, seven had underlying liver cirrhosis, including two with Budd-Chiari syndrome and one with cardiac cirrhosis. These cases were therefore classified as having FNH-like lesions. Two of the remaining 77 patients without underlying liver cirrhosis were positive for hepatitis B surface antigen. Seven of 50 (14.0%) patients evaluated by four-phase computed tomography (CT) showed portal or delayed washout, and three of 28 (10.7%) patients analyzed by three-phase CT showed washout on the portal phase. Collectively, three of nine (33.3%) patients with risk factors for HCC could have been wrongly diagnosed with HCC based on the non-invasive diagnostic criteria for HCC. A central scar was observed in 30 patients (35.7%) radiologically. Among 62 patients who underwent percutaneous needle biopsy, four patients (6.5%) were misdiagnosed as having HCC and two patients (3.2%) had inconclusive results by a first needle biopsy.

Conclusions: The presence of a hepatic lesion with arterial hypervascularity and/or portal/delayed washout is not necessarily diagnostic of HCC, particularly in patients without risk factors for HCC. These radiological findings can also occur in cirrhotic patients with FNH-like lesions, including those with hepatic outflow obstruction.

Citing Articles

Contrast-enhanced ultrasonography as a method of monitoring focal liver lesions - initial report.

Dobek A, Kobierecki M, Wieczorek P, Grzasiak O, Ciesielski W, Fabisiak A Clin Exp Hepatol. 2025; 10(2):120-128.

PMID: 39845349 PMC: 11748225. DOI: 10.5114/ceh.2024.140449.


Imaging characteristics of hypervascular focal nodular hyperplasia-like lesions in patients with chronic alcoholic liver disease.

Urase A, Tsurusaki M, Kozuki R, Kono A, Sofue K, Ishii K World J Gastroenterol. 2025; 31(2):98031.

PMID: 39811504 PMC: 11684202. DOI: 10.3748/wjg.v31.i2.98031.


Common pitfalls and diagnostic challenges in the application of LI-RADS CT/MRI algorithms: a comprehensive review.

Kamal O, Roudenko A, Diab M, Shenoy-Bhangle A, Lee J, Sirlin C Abdom Radiol (NY). 2024; .

PMID: 39718628 DOI: 10.1007/s00261-024-04778-8.


Radiopathologic findings of multifocal nodular hepatic steatosis.

Diop M, Sharma S, Samuel M, Byers J, McGeough A, Wahab S Radiol Case Rep. 2024; 19(8):3096-3101.

PMID: 38770382 PMC: 11103360. DOI: 10.1016/j.radcr.2024.04.029.


Focal Nodular Hyperplasia: A Comprehensive Review with a Particular Focus on Pathogenesis and Complications.

Villavicencio Kim J, Wu G J Clin Transl Hepatol. 2024; 12(2):182-190.

PMID: 38343607 PMC: 10851072. DOI: 10.14218/JCTH.2023.00265.